Serum cortisol concentration in patients with major depression after treatment with clomipramine

Pharmacological Reports

Volumn 61, Issue 4, 2009, Pages 604-611

  Piwowarska, Jadwiga ^a   Wrzosek, Małgorzata ^a   Radziwoń Zaleska, Maria ^a   Ryszewska Pokraśniewicz, Beata ^a   Skalski, Michał ^a   Matsumoto, Halina ^a   Biernacka Bazyluk, Agata ^a   Szelenberger, Waldemar ^a   Pachecka, Jan ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Clomipramine; Cortisol; Depression; Hypothalamic pituitary adrenal axis

Indexed keywords

CLOMIPRAMINE; HYDROCORTISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG MECHANISM; FEMALE; HAMILTON SCALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; MAJOR DEPRESSION; MALE; PATHOPHYSIOLOGY; REGULATORY MECHANISM; SCORING SYSTEM;

EID: 70549090063     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70112-4     Document Type: Article

References (27)

1. Baghai TC, Schüle C, Zwanzger P, Minov C, Holme C, Padberg F, Bidlingmaier M et al.: Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression. Psychoneuroendocrinology, 2002, 27, 385-399. (Pubitemid 34121980)
2. Ballmaier M, Narr KL, Toga AW, Elderkin-Thompson V, Elderkin-Thompson V, Thompson PM, Hamilton L et al.: Hippocampal morphology and distinguishing late-onset from early-onset elderly depression. Am J Psychiatry, 2008, 165, 229-237. (Pubitemid 351704523)
3. Bhagwagar Z, Hafizi S, Cowen PJ: Increased salivary cortisol after waking in depression. Psychopharmacology, 2005, 182, 54-57. (Pubitemid 41400861)
4. Bhagwagar Z, Hafizi S, Cowen PJ: Increase in concentration of waking salivary cortisol in recovered patients with depression. Am J Psychiatry, 2003, 160, 1890-1891. (Pubitemid 41103328)
5. Boyle MP, Brewer JA, Funatsu M, Woźniak DF, Tsien JZ, Izumi Y, Muglia LJ: Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc Natl Acad Sci, 2005, 102, 473-478. (Pubitemid 40116791)
6. Bremmer MA, Deeg DJ, Beekman AT, Penninx BW, Lips P, Hoogendijk WJ: Major depression in late life is associated with both hypo- and hypercortisolemia. Biol Psychiatry, 2007, 62, 479-486.
7. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS: Hippocampal volume reduction in major depression. Am J Psychiatry 2000, 157, 115-118. (Pubitemid 30027430)
8. Burke HM, Davis MC, Otte C, Mohr DC: Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology, 2005, 30, 846-856 (Pubitemid 40977907)
9. Cieślik K, Klenk-Majewska B, Danilczuk Z, Wróbel A, Łupina T, Ossowska G: Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats. Pharmacol Rep, 2007, 59, 46-52.
10. Goodman & Gilman's; The pharmacological basis of therapeutics 9th ed., Editors: Hardman JG, Limbird LE, McGraw-Hill, New York, 1996.
11. Holsboer F: The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology, 2000, 23, 477-501.
12. Pariante CM, Miller AH: Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry, 2001, 49, 391-404. (Pubitemid 32234301)
13. Pariante CM, Thomas SA, Lovestone S, Makoff A, Kerwin RW: Do antidepressants regulate how cortisol affects the brain? Psychoneuroendocrinology, 2004, 29, 423-447.
14. Posener JA, DeBattista Ch, Veldhuis JD, Province MA, Williams GH, Schatzberg AF: Process irregularity of cortisol and adrenocorticotropin secretion in men with major depressive disorder. Psychoneuroendocrinology, 2004, 29, 1129-1137.
15. Posener JA, DeBattista Ch, Williams GH, Chmura Kraemer H, Kalehzan BM, Schatzberg AF: 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry, 2000, 57, 755-760.
16. Posener JA, Wang L, Price JL, Gado MH, Province MA, Miller MI, Babb CM, Csernansky JG: High-dimensional mapping of the hippocampus in depression. Am J Psychiatry, 2003, 160, 83-89.
17. Radziwoń-Zaleska M, Matsumoto H, Skalski M, Androsiuk W, Dziklińska A, Kunicki, PK: Therapeutic drug monitoring in depression. Pol J Pharmacol, 2000, 52, 255-266.
18. Radziwoń-Zaleska M, Matsumoto H, Skalski M, Wilkowska J, Januszko P, Matoszko D, Dziklińska A et al.: Therapeutic tricyclic antidepressant drug in younger and older depressive patients. Pharmacol Rep, 2006, 58, 501-506. (Pubitemid 44389015)
19. Roche M, Shanahan E, Harkin A, Kelly JP: Trans-species assesment of antidepressant activity in a rodent model of depression. Pharmacol Rep, 2008, 60, 404-408.
20. Rogóż Z, Skuza G, Leśkiewicz M, Budziszewska B: Effects of co-administration of fluoxetine or tianeptine with metyrapone on immobility time and plasma corticosterone concentration in rats subjected to the forced swim test. Pharmacol Rep, 2008, 60, 880-888.
21. Roy M, Sapolsky RM: The exacerbation of hippocampal excitotoxicity by glucocorticoids is not mediated by apoptosis. Neuroendocrinology, 2003, 77, 24-31. (Pubitemid 36302419)
22. 2 receptors. Psychopharmacology, 1998, 140, 120-122.
23. Stokes PE: The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur Neuropsychopharmacol, 1995, 5, Suppl 77-82.
24. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th ed., Ed. Burtis CA, Ashwood ER, Bruns DE, Saunders, St. Louis, 2006.
25. Tse WS, Bond AJ: Relationship between baseline cortisol, social functioning and depression: a mediation analysis. Psychiatry Res, 2004, 126, 197-201.
26. Young EA, Carlson NE, Brown MB.: Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology, 2001, 25, 267-276.
27. Young EA, Veldhuis JD: Disordered adrenocorticotropin secretion in women with major depression. J Clin Endocrinol Metab, 2006, 91, 1924-1928.